Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement (Form S-8) pertaining to the 2021 Inducement Equity Incentive Plan and 2022 Equity Incentive Plan of Gain Therapeutics, Inc. of our report dated March 25, 2022, with respect to the consolidated financial statements of Gain Therapeutics, Inc. included in its Annual Report (Form 10-K) for the year ended December 31, 2021, filed with the Securities and Exchange Commission.
/s/ Ernst & Young AG
Lugano, Switzerland
July 15, 2022
